Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 14/20 | 0.39 |
| ▸ | USP7 | Q93009 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.37 |
| ▸ | BRD2 | P25440 | 2/20 | 0.36 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1670622 | 0.84 | ERN1 (0.39) | ERN1BRD4MLYCDBRD2FFAR1 | |
| SCHEMBL1672894 | 0.84 | ERN1 (0.38) | ERN1BRD4USP7MLYCDBRD2 | |
| SCHEMBL1672896 | 0.84 | ERN1 (0.38) | ERN1BRD4USP7MLYCDBRD2 | |
| SCHEMBL1672899 | 0.82 | ERN1 (0.38) | ERN1BRD4MLYCDFFAR1CREBBP | |
| SCHEMBL12800382 | 0.78 | MLYCD (0.42) | ERN1BRD4MLYCDBRD2BRD3 | |
| SCHEMBL12801015 | 0.77 | MLYCD (0.45) | ERN1BRD4USP7MLYCDBRD2 | |
| SCHEMBL12801001 | 0.74 | BRD4 (0.39) | ERN1BRD4MLYCDBRD2BRD3 | |
| SCHEMBL12800390 | 0.72 | BRD4 (0.43) | ERN1BRD4USP7MLYCDBRD2 | |
| SCHEMBL12362813 | 0.71 | BRD4 (0.66) | ERN1BRD4MLYCDBRD2CREBBP | |
| SCHEMBL12808114 | 0.70 | BRD4 (0.45) | ERN1BRD4MLYCDBRD2BRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011042477-A1 | SUBSTITUTED PYRROLES AND IMIDAZOLES AS ESTROGEN RECEPTOR LIGANDS | KARO BIO AB (SE) | 2011-04-14 | — | — | WO | disclosed |